Log in or Sign up for Free to view tailored content for your specialty!
Anemia Management News
Iron deficiency linked to kidney outcomes in non-dialysis-dependent CKD without anemia
Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study.
Akebia Therapeutics, US Renal Care enter deal to offer Vafseo to patients on dialysis
Akebia Therapeutics and U.S. Renal Care have entered a multiyear commercial supply contract to offer the anemia drug Vafseo to patients on dialysis, according to a press release.
Akebia readies launch of anemia drug Vafseo; planning talks with FDA on pre-dialysis use
As Akebia Therapeutics announced plans to launch its anemia drug Vafseo to the dialysis community, company officials said they intend to work with the FDA for more testing of the drug for the pre-dialysis market.
Log in or Sign up for Free to view tailored content for your specialty!
Hydralazine-induced autoimmune conditions may include drug-induced lupus, vasculitis
LONG BEACH, Calif. — Hydralazine-induced autoimmune conditions may have a varied presentation, including drug-induced lupus or vasculitis, according to a speaker, here.
Study finds clinicians do not consistently use algorithms when dosing Mircera
LONG BEACH, Calif. — Clinicians do not consistently use algorithms for dosing methoxy polyethylene glycol-epoetin beta when treating patients with anemia, presented research shows.
Investigational drug that reduces hepcidin offers promise for treating anemia
LONG BEACH, Calif. — Researchers reported results from a phase 1b/2a placebo-controlled study of DISC-0974, an anti-hemojuvelin antibody to treat anemia in patients with chronic kidney disease.
Akebia receives FDA approval for anemia drug Vafseo
Akebia Therapeutics Inc. has received FDA approval for its oral anemia drug Vafseo for treating anemia in adults with end-stage kidney disease on dialysis for at least 3 months.
Revisit news and research in anemia
Healio has compiled a list of its most-read anemia care news in 2023.
Study: More staff, communication needed after ‘graduating’ patients after transplantation
PHILADELPHIA — Many kidney transplant patients successfully advance from transplant centers back to their local nephrologists, but providers find there is room for improvement in the transition, according to data presented at ASN Kidney Week.
Wish reviews progress in anemia management and potential for a new drug class
Healio | Nephrology News & Issues interviewed Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for dialysis at Indiana University Health in Indianapolis, about the role of anemia management in kidney care. Wish is also chair of the Editorial Advisory Board for Healio | Nephrology News & Issues.
-
Headline News
New website guides patients, ECPs through proper disposal of contact lenses
April 21, 20253 min read -
Headline News
Plant-centered diets improve health among patients with lung diseases
April 22, 202512 min read -
Headline News
PCPs need to be ‘familiar with and skilled in’ GLP-1 prescribing as use rises in US
April 22, 20253 min read
-
Headline News
New website guides patients, ECPs through proper disposal of contact lenses
April 21, 20253 min read -
Headline News
Plant-centered diets improve health among patients with lung diseases
April 22, 202512 min read -
Headline News
PCPs need to be ‘familiar with and skilled in’ GLP-1 prescribing as use rises in US
April 22, 20253 min read